Application of precision medicine based on next-generation sequencing and immunohistochemistry in ovarian cancer: a real-world experience.

A comprehensive review of germline mutation, IHC, and tumor NGS helped identify candidates for precision therapy in patients with ovarian cancer, a proportion of whom received matched therapy.